Tata Chemicals shares gained over 4% in early trade after reports suggested fresh momentum around a potential listing of Tata Sons, the holding company of the Tata Group.
According to a report by The Economic Times, Tata Trusts vice chairman Venu Srinivasan has backed the idea of a public listing of Tata Sons. This marks the first instance of a Tata Trusts trustee publicly supporting such a move, indicating a possible shift in stance within the group’s leadership.
Srinivasan reportedly said that a listing could become inevitable if the Reserve Bank of India classifies Tata Sons as an upper-layer non-banking financial company (NBFC), a designation that comes with stricter regulatory requirements, including a potential listing mandate.
He further noted that a public listing would help unlock value for minority shareholders. This includes providing an exit route to the Shapoorji Pallonji Group, which holds an 18.37% stake in Tata Sons and has long sought liquidity to reduce its debt burden. Additionally, the move could equip Tata Sons with capital to sustain its long-term growth trajectory.
The developments appear to have lifted sentiment across Tata Group-linked stocks, with Tata Chemicals reacting positively to the news flow.
At the time of reporting, Tata Chemicals shares were trading at ₹674.85, up ₹26.90 or 4.15% on the NSE. The stock opened at ₹652 and touched an intraday high of ₹679.90, with a low of ₹652. Its 52-week range stands between ₹580.30 and ₹1,026.65, while traded volume was at 5,98,276 shares.
Why and how does Tata Chemicals benefit from Tata Sons listing?
Tata Sons listing is a significant positive trigger for Tata Chemicals primarily because of the value unlocking it enables through the company’s stake in the Tata Group holding company. Tata Chemicals holds a 2.53% stake in Tata Sons, and this investment was made years ago at valuations far below what the holding company is worth today. For over two decades, equity markets assigned little to no value to this stake due to the complete absence of any monetisation pathway. The current market value of all listed investments held by Tata Sons is around Rs 16 lakh crore, and even after applying a 50% holding company discount and a further 20% haircut for impact cost and taxes, Tata Chemicals’ stake could be worth up to Rs 650 per share — purely as optionality value from a Tata Sons IPO. Among all listed Tata Group companies that hold a stake in Tata Sons, Tata Chemicals stands out with a disproportionately high holding value relative to its overall market capitalisation — making it the most leveraged proxy play on a Tata Sons listing.